Clinical trial
A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD…
NCT00475735 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00475735 |
|---|---|
| Title | A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED) |
| Official title | A Phase IIa, Randomized, Double-Blind, Placebo-Controlled, Incomplete Block, Two-period, Crossover Clinical Trial to Study the Safety and Efficacy of MK0249, 10 mg, for Adult Patients, Ages 18 to 55, With Attention Deficit Hyperactivity Disorder (ADHD) |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Attention-Deficit/Hyperactivity Disorder (ADHD) |
| Intervention type | Drug |
| Interventions | MK0249, Concerta (methylphenidate), Placebo |
| Enrollment | 72 |
| Start date | Jul 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | May 21, 2007 |
| Last update posted | Jul 28, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: